TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FLNA

Filana Therapeutics, Inc.

Healthcare · Biotechnology

0.7728$ -11.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement FLNA
Line item Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
– – – – – – – – –
– – – – – – -33.8% +23.5% –
– – – – – – – – –
– +16.1% -33.4% -62.6% -22.7% -2.6% +17.9% -27.3% –
– -30.8% +21.9% +268.8% -80.4% +22.7% -31.7% -8.1% –
– -3.7% -16.6% +84.6% -73.9% +11.2% -17.1% -16.8% –
– – – – – – – – –
– – – – – – – – –
– – – – – – – – –
– – – – – – – – –

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?